Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Greg Fulcher"'
Autor:
Katherine M. Wang, JingWei Li, Vivek Bhalla, Meg J. Jardine, Bruce Neal, Dick deZeeuw, Greg Fulcher, Vlado Perkovic, Kenneth W. Mahaffey, Tara I. Chang
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 4, Iss 3, Pp n/a-n/a (2021)
Abstract Background Patients with type 2 diabetes (T2D) are predisposed to derangements in serum Magnesium (Mg), which may have implications for cardiometabolic events and outcomes. In clinical trials, participants with T2D randomized to sodium‐glu
Externí odkaz:
https://doaj.org/article/72a67cd8e6f54f149a0e49822944b289
Autor:
Tim Usherwood, Peter G Kerr, Kevan R Polkinghorne, Edward Zimbudzi, Clement Lo, Sanjeeva Ranasinha, Helena Teede, Greg Fulcher, Steven Jan, Rowan Walker, Greg Johnson, Sophia Zoungas
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 8, Iss 1 (2020)
ObjectiveTo evaluate the impact of an integrated diabetes and kidney disease model of care on health-related quality of life (HRQOL) of patients with comorbid diabetes and chronic kidney disease (CKD).Research design and methodsA longitudinal study o
Externí odkaz:
https://doaj.org/article/99f7f2877b7e42e68e218fd044560100
Autor:
Clement Lo, Dragan Ilic, Helena Teede, Alan Cass, Greg Fulcher, Martin Gallagher, Greg Johnson, Peter G Kerr, Tim Mathew, Kerry Murphy, Kevan Polkinghorne, Rowan Walker, Sophia Zoungas
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0146615 (2016)
BACKGROUND:Multi-morbidity due to diabetes and chronic kidney disease (CKD) remains challenging for current health-systems, which focus on single diseases. As a first step toward health-care improvement, we explored the perspectives of patients and t
Externí odkaz:
https://doaj.org/article/e3854b9876fb44afb5610866cac50daf
Autor:
Jun Hata, Hisatomi Arima, Sophia Zoungas, Greg Fulcher, Carol Pollock, Mark Adams, John Watson, Rohina Joshi, Andre Pascal Kengne, Toshiharu Ninomiya, Craig Anderson, Mark Woodward, Anushka Patel, Giuseppe Mancia, Neil Poulter, Stephen MacMahon, John Chalmers, Bruce Neal, ADVANCE Collaborative Group
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e55807 (2013)
Endpoint adjudication committees (EPAC) are widely used in clinical trials. The aim of the present analysis is to assess the effects of the endpoint adjudication process on the main findings of the ADVANCE trial (Trial registration: ClinicalTrials.go
Externí odkaz:
https://doaj.org/article/4261a7988a994fea97d1ceec83f4e6e1
Autor:
Clare Arnott, Tamara Young, Jingwei Li, Hiddo J.L. Heerspink, Kenneth W. Mahaffey, Sophia Zoungas, Amy Kang, Vlado Perkovic, Brendon L. Neuen, Bruce Neal, Dick de Zeeuw, Carinna Hockham, Meg Jardine, Greg Fulcher
Publikováno v:
Diabetologia, 64(11), 2402-2414. SPRINGER
Aims/hypothesis Type 2 diabetes mellitus can manifest over a broad clinical range, although there is no clear consensus on the categorisation of disease complexity. We assessed the effects of canagliflozin, compared with placebo, on cardiovascular an
Autor:
Kenneth W. Mahaffey, Clare Arnott, Min Jun, Sophia Zoungas, Greg Fulcher, Dick de Zeeuw, Brendon L. Neuen, Carol A. Pollock, Meg Jardine, Bruce Neal, Gemma A. Figtree, Hiddo J.L. Heerspink, Vlado Perkovic
Publikováno v:
Diabetes obesity & metabolism, 23(2), 382-390. Wiley
Diabetes, Obesity & Metabolism
Diabetes, Obesity & Metabolism
Aim To assess whether the effects of sodium-glucose co-transporter-2 (SGLT2) inhibitors on cardiovascular, kidney and mortality outcomes are consistent with and without concomitant metformin use.Material and methods We conducted a meta-analysis of ev
Autor:
Greg Fulcher, Brendon L. Neuen, Dick de Zeeuw, Qiang Li, Meg Jardine, Kenneth W. Mahaffey, David R. Matthews, Hiddo J.L. Heerspink, Richard Oh, Vlado Perkovic, Bruce Neal, Toshiaki Ohkuma
Publikováno v:
J Am Soc Nephrol
Journal of the American Society of Nephrology, 30(11), 2229-2242. AMER SOC NEPHROLOGY
Journal of the American Society of Nephrology, 30(11), 2229-2242. AMER SOC NEPHROLOGY
BACKGROUND: If SGLT2 inhibitors protect the kidneys by reducing albuminuria as hypothesized, people with type 2 diabetes mellitus (T2DM) with higher albuminuria should benefit more. METHODS: We conducted a post-hoc analysis of data from the CANaglifl
Autor:
Dick de Zeeuw, Kent Y Feng, Greg Fulcher, Meg Jardine, David R. Matthews, Juliana Ianus, Michael Pfeifer, Kenneth W. Mahaffey, Vlado Perkovic, Bruce Neal, Jingwei Li
Aims To determine the reasons for hospitalizations in the CANagliflozin cardioVascular Assessment Study (CANVAS) Program and the effects of the sodium glucose co-transporter 2 inhibitor canagliflozin on hospitalization. Materials and methods A second
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b9acd312a343c726758cc599b11b12f
http://hdl.handle.net/10044/1/94091
http://hdl.handle.net/10044/1/94091